×
About 37,652 results

ALLMedicine™ Acute Coronary Syndrome Center

Research & Reviews  17,913 results

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients o...
https://doi.org/10.1177/1074248420968706
Journal of Cardiovascular Pharmacology and Therapeutics; Wadowski PP, Pultar J et. al.

Oct 27th, 2020 - Since data on the agreement between light transmission aggregometry (LTA) and multiple electrode aggregometry (MEA) in patients on the more potent P2Y12 inhibitors are missing so far, we investigated if the evaluation of the responsiveness to ther...

Factors Influencing Provider and Patient Choice of P2Y12 Inhibitor Therapy.
https://doi.org/10.1177/0897190020966174
Journal of Pharmacy Practice; Benitez RM, Lusk KA et. al.

Oct 27th, 2020 - Clopidogrel is the most commonly prescribed P2Y12 inhibitor for acute coronary syndrome (ACS) or stent placement, though ticagrelor or prasugrel may be preferred. Medication-related factors may influence selection of therapy. To determine which fa...

Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients W...
https://doi.org/10.1001/jama.2020.16167
JAMA You SC, Rho Y et. al.

Oct 27th, 2020 - Current guidelines recommend ticagrelor as the preferred P2Y12 platelet inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large randomized clinical trial. The benefits and risks associated with ticagrelor vs cl...

Prospective study of the effect of sulfotanshinone sodium combined with tirofiban on va...
https://doi.org/10.1111/jcpt.13283
Journal of Clinical Pharmacy and Therapeutics REFERENCES; Lin S, He X et. al.

Oct 26th, 2020 - This study aimed to explore the effect of sulfotanshinone sodium injection combined with tirofiban on vascular endothelial function and indicators of plaque stability in elderly patients with acute coronary syndrome (ACS). We designed a prospectiv...

Comparison of High-Sensitivity Troponin T Assay to Conventional Troponin T Assay for Ru...
https://doi.org/10.1097/TME.0000000000000324
Advanced Emergency Nursing Journal; Mungai E, Hamilton BK et. al.

Oct 26th, 2020 - Approximately 5% of all emergency department (ED) visits require evaluation of chest pain and atypical symptoms for diagnosis or exclusion of myocardial infarction or acute coronary syndrome (ACS) (P. ). Health care providers rely on effective tes...

see more →

Guidelines  47 results

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239193
European Heart Journal; Chieffo A, Stefanini GG et. al.

May 14th, 2020 - The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses a risk to both patients an...

ACR Appropriateness Criteria® Chest Pain-Possible Acute Coronary Syndrome.
https://doi.org/10.1016/j.jacr.2020.01.027
Journal of the American College of Radiology : JACR; , Batlle JC et. al.

May 5th, 2020 - Chest pain is a frequent cause for emergency department visits and inpatient evaluation, with particular concern for acute coronary syndrome as an etiology, since cardiovascular disease is the leading cause of death in the United States. Although ...

The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendation...
https://doi.org/10.1253/circj.CJ-19-0874
Circulation Journal : Official Journal of the Japanese Circulation Society; Tan WCJ, Inoue K et. al.

Dec 19th, 2019 - The Asia-Pacific Society of Cardiology (APSC) high-sensitivity troponin T (hs-TnT) consensus recommendations and rapid algorithm were developed to provide guidance for healthcare professionals in the Asia-Pacific region on assessing patients with ...

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Intensive Lipid Lowering in Elderly Patients
https://jamanetwork.com/journals/jamacardiology/article-abstract/2738100
JAMA Cardiology; Gotto,A.

Jul 16th, 2019 - In this issue of JAMA Cardiology, a prespecified post hoc analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) examines the effect of age on higher-intensity lipid lowering in patients after an acute co...

see more →

Drugs  251 results see all →

Clinicaltrials.gov  18,593 results

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients o...
https://doi.org/10.1177/1074248420968706
Journal of Cardiovascular Pharmacology and Therapeutics; Wadowski PP, Pultar J et. al.

Oct 27th, 2020 - Since data on the agreement between light transmission aggregometry (LTA) and multiple electrode aggregometry (MEA) in patients on the more potent P2Y12 inhibitors are missing so far, we investigated if the evaluation of the responsiveness to ther...

Factors Influencing Provider and Patient Choice of P2Y12 Inhibitor Therapy.
https://doi.org/10.1177/0897190020966174
Journal of Pharmacy Practice; Benitez RM, Lusk KA et. al.

Oct 27th, 2020 - Clopidogrel is the most commonly prescribed P2Y12 inhibitor for acute coronary syndrome (ACS) or stent placement, though ticagrelor or prasugrel may be preferred. Medication-related factors may influence selection of therapy. To determine which fa...

Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients W...
https://doi.org/10.1001/jama.2020.16167
JAMA You SC, Rho Y et. al.

Oct 27th, 2020 - Current guidelines recommend ticagrelor as the preferred P2Y12 platelet inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large randomized clinical trial. The benefits and risks associated with ticagrelor vs cl...

Prospective study of the effect of sulfotanshinone sodium combined with tirofiban on va...
https://doi.org/10.1111/jcpt.13283
Journal of Clinical Pharmacy and Therapeutics REFERENCES; Lin S, He X et. al.

Oct 26th, 2020 - This study aimed to explore the effect of sulfotanshinone sodium injection combined with tirofiban on vascular endothelial function and indicators of plaque stability in elderly patients with acute coronary syndrome (ACS). We designed a prospectiv...

Comparison of High-Sensitivity Troponin T Assay to Conventional Troponin T Assay for Ru...
https://doi.org/10.1097/TME.0000000000000324
Advanced Emergency Nursing Journal; Mungai E, Hamilton BK et. al.

Oct 26th, 2020 - Approximately 5% of all emergency department (ED) visits require evaluation of chest pain and atypical symptoms for diagnosis or exclusion of myocardial infarction or acute coronary syndrome (ACS) (P. ). Health care providers rely on effective tes...

see more →

News  821 results

Cardiogenic Shock Rate Soars in COVID-Positive ACS
https://www.medscape.com/viewarticle/939604

Oct 21st, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19–positive patients undergoing an invasive strategy for acute coronary syndrome presented hours later than uninfected historical controls, ...

Acute Coronary Syndromes Clinical Practice Guidelines (ESC, 2020)
https://reference.medscape.com/viewarticle/938204

Sep 29th, 2020 - In late August 2020, the European Society of Cardiology (ESC) released their updated guidelines for the diagnosis and management of non ST-elevation (NSTE) acute coronary syndrome (ACS).[1,2] The updates place increased reliance on high-sensitivit...

Fast Five Quiz: Atrial Fibrillation and Acute Coronary Syndrome
https://reference.medscape.com/viewarticle/937209

Sep 16th, 2020 - Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia, and it exerts a significant burden on individuals and healthcare systems around the world. In 2017, 37.5 million cases of AF were recorded globally, which represented a 33...

Fast Five Quiz: Atrial Fibrillation and Acute Coronary Syndrome
https://reference.medscape.com/viewarticle/937209_6

Sep 16th, 2020 - Head-to-head randomized trials comparing the different P2Y12 inhibitors as part of combination antithrombotic therapy have not been conducted. Most trials of combination antithrombotic therapy used clopidogrel; some others used ticagrelor or prasu...

ESC's Revised NSTE-ACS Guidelines Embrace hsT, Personalized Anti-Ischemia Treatments
https://www.medscape.com/viewarticle/936676

Aug 31st, 2020 - The first revision since 2015 to the European Society of Cardiology's guidelines for diagnosing and managing non ST-elevation acute coronary syndrome placed increased reliance on high-sensitivity cardiac troponin testing for diagnosis, and embrace...

see more →

Patient Education  27 results see all →